Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of Alabama at Birmingham
Cedars-Sinai Medical Center
Universidade Federal de Pernambuco
Celgene
Amgen